DBV Technologies SA ADR

23 مارس 2026، 11:47 م UTC

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 مارس 2026، 10:55 م UTC

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 مارس 2026، 09:51 م UTC

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 مارس 2026، 11:59 م UTC

Global Equities Roundup: Market Talk

23 مارس 2026، 11:59 م UTC

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 مارس 2026، 11:50 م UTC

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 مارس 2026، 11:37 م UTC

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 مارس 2026، 10:42 م UTC

Global Equities Roundup: Market Talk

23 مارس 2026، 10:42 م UTC

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 مارس 2026، 10:40 م UTC

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 مارس 2026، 10:23 م UTC

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 مارس 2026، 10:22 م UTC

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 مارس 2026، 10:21 م UTC

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 مارس 2026، 10:21 م UTC

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 مارس 2026، 10:20 م UTC

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 مارس 2026، 10:20 م UTC

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 مارس 2026، 10:19 م UTC

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 مارس 2026، 10:19 م UTC

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 مارس 2026، 10:18 م UTC

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 مارس 2026، 10:15 م UTC

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 مارس 2026، 10:08 م UTC

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 مارس 2026، 09:42 م UTC

Global Forex and Fixed Income Roundup: Market Talk

23 مارس 2026، 09:42 م UTC

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 مارس 2026، 09:32 م UTC

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 مارس 2026، 09:32 م UTC

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 مارس 2026، 09:32 م UTC

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 مارس 2026، 09:10 م UTC

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 مارس 2026، 08:50 م UTC

Tech, Media & Telecom Roundup: Market Talk

23 مارس 2026، 08:50 م UTC

Health Care Roundup: Market Talk

23 مارس 2026، 08:50 م UTC

Basic Materials Roundup: Market Talk